PRINCETON, N.J. — Dr. Reddy’s announced Monday the launch of lansoprazole delayed-release capsules USP, 15 mg, an over-the-counter (O-T-C) store-brand equivalent of Prevacid 24HR capsules, in the United States market, as approved by the U.S. Food and Drug Administration.
Dr. Reddy’s O-T-C lansoprazole delayed-release capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn occurring two or more days a week.
“We are pleased to continue to expand our antacids and PPI portfolio for our customers,” says Milan Kalawadia, senior vice president and head of U.S. O-T-C and Specialty Rx Divisions, Dr. Reddy’s Laboratories. “We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”
The Prevacid 24HR brand and generic had U.S. sales of approximately $57 million MAT for the most recent twelve months ending in August 2019 according to IRi.
Dr. Reddy’s O-T-C lansoprazole delayed-release capsules USP, 15 mg, are available in 14, 28 and 42 count sizes.
